Introduction {#s1}
============

The human corneal endothelium (CE), comprised of a monolayer of hexagonal corneal endothelial cells (CECs) attached to a basement Descemet's membrane (DM) composed of collagen, forms a selective barrier between the anterior chamber of the eye and the corneal stroma. CECs are the most metabolically active cells in the cornea expressing fluid pumps that actively move fluid from the stroma back into the anterior chamber of the eye. The dynamic balance between the "leaky" barrier and constant pump activity maintains corneal deturgescence, thereby keeping the cornea transparent. Corneal blindness is often due to endothelial dysfunction and is the second leading cause of visual impairment [@pone.0067546-Peh1].

Human CECs have limited proliferative capacity within the eye [@pone.0067546-Bourne1], [@pone.0067546-Joyce1]. Hence, in order to replace dead or damaged CECs, existing cells spread out to maintain the functional integrity of the CE [@pone.0067546-Kaufman1], [@pone.0067546-Edelhauser1]. In cases of severe cell loss due to genetic corneal endothelial dystrophy or trauma, decompensation of the CE may occur, reducing its capacity to pump fluid out of the stroma, resulting in stromal and epithelial edema, loss of corneal clarity and visual acuity, and eventually bullous keratopathy [@pone.0067546-Peh1]. The conventional solution to restore vision is through cornea transplantation. However, there is a global shortage of transplant-grade donor cornea. This shortage is expected to worsen as the demand for corneal transplantation increases with an aging global population. Therefore, considerable interest has been generated for the development of suitable endothelial grafts through tissue engineering, which can potentially alleviate the shortage of corneal transplant material.

With the introduction of surgical procedures such as Descemet's Stripping Endothelial Keratoplasty (DSEK) and Descemet's Membrane Endothelial Keratoplasty (DMEK), less invasive, key-hole surgery options for the selective replacement of the CE layer are now possible [@pone.0067546-Melles1], [@pone.0067546-Rose1], [@pone.0067546-Tan1]. The advent of such surgical procedures provides further impetus for the development of alternative endothelial grafts -- either by means of *ex vivo* expansion of human CECs, or by *de novo* generation of CECs from pluripotent human embryonic stem cells, induced pluripotent stem cells or multipotent adult stem cells, which are unlimited sources of cells. However, a major obstacle to such endeavors is the lack of specific markers for CECs, resulting in an inability to definitively identify such putative stem cell-derived CECs.

Currently, the most commonly used markers in the characterization of cultivated CECs include ZO-1 [@pone.0067546-Barry1], [@pone.0067546-Sugrue1], a tight junction protein involved in signal transduction at cell-cell junctions, and Na^+^/K^+^-ATPase [@pone.0067546-Savion1], an essential enzyme involved in the active transport of ions across the CE. Although the co-expression of both proteins indicates the presence of key components of CE fluid transport function, it is not a definite indication of the identity of CECs because both ZO-1 and Na^+^/K^+^-ATPase are ubiquitously expressed in many other cell types [@pone.0067546-Corti1], [@pone.0067546-Sanchez1], [@pone.0067546-Sune1], [@pone.0067546-Bonting1].

This paper presents a thorough gene expression analysis of CECs and proposes a panel of markers that reliably identifies CECs *in vivo* and *in vitro*. We used RNA-sequencing (RNA-seq) [@pone.0067546-Wang1] and High Throughput Quantitative Polymerase Chain Reaction (HT-PCR), together with various Bioinformatics platforms such as BioGPS (<http://biogps.org>), DAVID Functional Annotation Clustering Tool [@pone.0067546-Huangda1] and PANTHER Classification System [@pone.0067546-Mi1], to select a panel of markers based on the following criteria:

1.  Highly expressed in CECs from young and old donors:

2.  Expressed in CECs *in vivo*, as well as in *ex vivo* CEC cultures;

3.  Ideally not expressed in other cell types;

4.  Not expressed in corneal stroma keratocytes or activated corneal stroma fibroblasts.

Results {#s2}
=======

To identify markers for CECs, global gene expression analysis of CECs stripped from donor cornea along with the Descemet's membrane (CEC-DM) was carried out using RNA-seq [@pone.0067546-Tang1]. Gene lists generated were analyzed using DAVID Functional Annotation Clustering Tool [@pone.0067546-Huangda1] and PANTHER Classification System [@pone.0067546-Mi1] to identify over-represented ontology groups and molecular pathways.

Identification of Genes most Highly Expressed in CECs {#s2a}
-----------------------------------------------------

Gene expressions of the following samples were analyzed using RNA-sequencing: 1) CEC-DM pooled from 5 young donors; 2) CEC-DM pooled from 5 old donors; 3) CEC cultures and 4) corneal stroma pooled from 5 young donors ([Figure 1](#pone-0067546-g001){ref-type="fig"}). Description of the isolation process can be found in [Materials and Methods](#s4){ref-type="sec"}. Full dataset for the RNA-sequencing performed is found in [Table S1](#pone.0067546.s001){ref-type="supplementary-material"}.

![The human corneal tissue, the isolated endothelium and the cultured corneal endothelial cells.\
A. Corneal stroma with an intact Descemet's membrane (DM), arrowed (left) and a corneal stromal without the DM layer (right). B. Peeled CEC-DM complex in a typical DM-roll, with the endothelium on the outside. C. Confluent culture of human CECs at the second passage. Scale bars: 100 µm.](pone.0067546.g001){#pone-0067546-g001}

The sequence depth ranged from 1.8 million to 4.6 million reads ([Figure 2A](#pone-0067546-g002){ref-type="fig"}). Hierarchical clustering showed that the young and old CEC-DMs cluster closest to each other, followed by CEC culture, and lastly the corneal stroma ([Figure 2B](#pone-0067546-g002){ref-type="fig"}). This indicates that the two CEC-DM samples are closer in gene expression than they are to the CEC culture, and that the corneal stroma sample has the greatest gene expression difference compared to the other 3 samples.

![RNA-seq comparing gene expression of young and old CEC-DM, CEC culture and corneal stroma.\
A. Sequencing depth (total uniquely mapping reads) of each sample. B. Hierarchical clustering shows that the young and old CECs cluster closer to each other, followed by CEC culture, and lastly the corneal stroma.](pone.0067546.g002){#pone-0067546-g002}

We first sought to identify the genes most highly expressed in the young CECs. The top 20 genes expressed in CECs include those that play a role in cellular metabolism (ENO1, GAPDH, CA3, LDHA, ALDOA, ATP5B, ATP5A1), and genes important for trans-membrane transport (SLC2A1, ATP5B, ATP1A1, ATP5A1) ([Table 1](#pone-0067546-t001){ref-type="table"}). Some of these genes have also been previously identified to be highly expressed in CECs. CA3, PTGDS, LDHA, MGP, and C4orf49 have been identified by Sakai et al. [@pone.0067546-Sakai1], while ENO1, GAPDH, and PTGDS have been noted by Gottsh et al. [@pone.0067546-Gottsch1] to be among the top 50 most highly expressed genes in CECs.

10.1371/journal.pone.0067546.t001

###### List of top 20 most highly expressed genes in human corneal endothelium.

![](pone.0067546.t001){#pone-0067546-t001-1}

  Gene                                                                    Description                                                                  PreviouslyIdentified
  --------- ---------------------------------------------------------------------------------------------------------------------------------------- ------------------------
  ENO1                                   Enzyme important for glycolysis; also functions as a structural lens protein.                                     Gottsch 2003
  GAPDH                                                         Enzyme important for glycolysis.                                                           Gottsch 2003
  CA3                    Enzyme important for cellular metabolism and carbon dioxide transport; reversible hydration of carbon dioxide.                     Sakai 2002
  MYOC             Secreted glycoprotein expressed in trabecular meshwork and ciliary body; participates in regulating intraocular pressure.         
  SLC2A1                                                       Facilitative glucose transporter.                                                     
  PTGDS                Synthesizes prostaglandin PGD2; PGD2 lowers intraocular pressure and triggers inflammatory effects on conjunctiva.             Sakai 2002Gottsch 2003
  IER3                                  Protects cells from Fas- or tumor necrosis factor type alpha-induced apoptosis.                              
  VIM           Organizer proteins involved in attachment, migration, signaling; mutations in this gene causes a dominant, pulverulent cataract.     
  TPT1                                                   Calcium binding and microtubule stabilization.                                              
  ATP5B                                                       Mitochondrial membrane ATP synthase.                                                   
  LDHA                                                          Enzyme important for glycolysis.                                                            Sakai 2002
  TSPAN6                       Mediates signal transduction events; regulates cell development, activation, growth and motility.                     
  MGP             Associates with the organic matrix of bone and cartilage. Inhibitor of bone formation. Prevents calcification of the cornea.              Sakai 2002
  ALDOA                                               Enzyme important for glycolysis and gluconeogenesis.                                           
  HERPUD1                                    Component of the endoplasmic reticulum quality control (ERQC) system.                                   
  C4orf49    Corneal Endothelial Specific Protein 1. Expressed in corneal endothelium, corneal epithelium, cultured CECs, brain, testis, and ovary.         Sakai 2002
  RPL3                                              Component of the large subunit of cytoplasmic ribosomes.                                         
  UBC                                                                     Ubiquitin C.                                                               
  ATP1A1                      Na^+^/K^+^-ATPase responsible for establishing Na^+^ and K^+^ gradients essential for osmoregulation                   
  ATP5A1              Mitochondrial membrane ATP synthase; produces ATP from ADP in the presence of a proton gradient across the membrane            

Information from description was taken from Genecards.org, unless otherwise specified.

Furthermore, analysis using the DAVID Functional Annotation Clustering Tool showed that the most over-represented ontological groups for the top 200 genes in young CECs are cellular metabolism, regulation of cell death, and membrane transport ([Table 2](#pone-0067546-t002){ref-type="table"}). Taken together, these results describe a cell type that is metabolically active, and have a function in ion and water transport, corroborating with previous descriptions of CECs [@pone.0067546-Peh1], [@pone.0067546-Bonanno1].

10.1371/journal.pone.0067546.t002

###### GO analysis using DAVID Functional Annotation (Subset: GOTERM_BP_FAT).

![](pone.0067546.t002){#pone-0067546-t002-2}

  Gene ontology term                                                      \%                                                 Genes
  --------------------------------------------------------------------- ------ -------------------------------------------------------------------------------------------------
  Generation of precursor metabolites and energy                         28.6   ALDOA, LDHA, ATP5B, ALDOC, PFKP, COX4I1, ATP5G3, TPI1, SLC25A3, GNAS, ATP5A1, PGK1, GAPDH, ENO1
  Response to organic substance                                          18.4                       HSP90AB1,FOS,HERPUD1,GLUL,ALDOC, MGP,GNAS,ATP5G3,HSPA8
  Glycolysis, catabolic processes                                        16.3                          ALDOA, TPI1, LDHA. ALDOC, PFKP, PGK1, GAPDH, ENO1
  Translation                                                            16.3                           NACA, RPL8, RPL3, UBC, EIF1, RPL11, RPS6, RPS8
  Translational elongation                                               12.2                                 RPL8, RPL3, UBC, RPL11, RPS6, RPS8
  Nitrogen compound biosynthetic process                                 12.2                             ALDOA, GLUL, ATP5B, ATP1A1, ATP5A1, ATP5G3
  Cation transport                                                       12.2                            SLC4A11, ATP5B, TPT1, ATP1A1, ATP5A1, ATP5G3
  Homeostatic process                                                    12.2                             ALDOA, HERPUD1, SLC4A11, ATP5B, TPT1, RPS6
  ATP/nucleotide biosynthetic process                                    10.2                                ALDOA, ATP5B, ATP1A1, ATP5A1, ATP5G3
  Monovalent inorganic cation transport                                  10.2                               SLC4A11, ATP5B, ATP1A1, ATP5A1, ATP5G3
  Proton Transport                                                       8.2                                    SLC4A11, ATP5B, ATP5A1, ATP5G3
  Response to protein stimulus                                           8.2                                     HSP90AB1, FOS, HERPUD1, HSPA8
  Organic aid biosynthetic process                                       8.2                                        TPI1, GLUL, PTGDS, SCD
  Response to extracellular stimulus                                     8.2                                        FOS, LDHA, COZ4I1, MGP
  Cation homeostasis                                                     8.2                                     HERPUD1, SLC4A11, ATP5B, TPT1
  Fructose metabolic process                                             6.1                                          ALDOA, ALDOC, PFKP
  ATP synthesis coupled proton transport, ion transmembrane transport    6.1                                         ATP5B, ATP5A1, ATP5G3
  Response to unfolded protein                                           6.1                                       HSP90AB1, HERPUD1, HSPA8
  Fatty acid biosynthetic process                                        6.1                                           TPI1, PTGDS, SCD
  Oxidative phosphorylation                                              6.1                                         ATP5B, ATP5A1, ATP5G3
  Aging                                                                  6.1                                          FOS, ALDOC, ATP5G3
  One-carbon metabolic process                                           6.1                                            FOS, CA12, CA3
  Biosynthetic/metabolic processes                                       4.1                                             ATP5B, ATP5A1
  Protein homotetramerization                                            4.1                                              ALDOC, PFKP

Top 200 genes with highest RPM value in young CEC-DM was analyzed in DAVID. GO terms that are over represented are ranked in descending order of percentage of genes representing this category. Related GO terms represented by the same set of genes were combined.

Analysis of Genes that have been Previously used as CEC Markers {#s2b}
---------------------------------------------------------------

We next examined the expression levels of commonly used CEC markers in our samples. [Table 3](#pone-0067546-t003){ref-type="table"} shows that most of the markers previously used by other groups are either not expressed in culture (reads per million (RPM) \<10), do not differentiate between CECs and stroma (fold change of young/stroma \<5), or lack specificity as catalogued in BioGPS. Of the genes listed, COL8A2 and SLC4A11 emerged from our study as the best candidates as markers for CECs, but these too are not ideal. Expression of COL8A2 is high in CECs and low in stroma, but is also present in the retina. SLC4A11 is highly expressed in CECs, not ubiquitously expressed in many cell types (data not shown), but is 6 times lower in expression in CEC cultures than in CEC-DM ([Table 3](#pone-0067546-t003){ref-type="table"}). Therefore, we sought to probe for other candidates that could be used to identify CECs.

10.1371/journal.pone.0067546.t003

###### Analysis of CEC markers used in other publications.

![](pone.0067546.t003){#pone-0067546-t003-3}

             RPM values   Fold change   Flaw                                           
  --------- ------------ ------------- ------ ------- ------ ------ ------ --- --- --- ---
  AQP1          233           172        4      506    1.35   54.0   0.5        Y   Y   Y
  ATP1A1       2,616         1,627      858     368    1.61   3.1    7.1                Y
  CLCN2          13            0         1       4     n/a    11.6   2.8    Y   Y   Y  
  CLCN3          15            5         79      5     2.82   0.2    3.0    Y       Y   Y
  COL8A2       1,821         1,743      859     107    1.04   2.1    17.0               R
  ENO2          495           247        57     104    2.0    8.7    4.8            Y   Y
  JAM1          0.80         0.50       3.70    86     1.60   0.22   0.01   Y   Y   Y   Y
  NCAD          129           67         94      4     1.92   1.4    33.3               Y
  PTGDS        5,547         6,415      183    2,522   0.86   30.2   2.2        ?   Y   Y
  SLC4A11      2,313         2,940      366     90     0.79   6.3    25.7       ?      
  SLC4A4        113           221        41     29     0.51   2.8    3.9            Y   Y
  VDAC2         248           135       134     172    1.83   1.9    1.4            Y   Y
  VDAC3         582           393       299     250    1.48   2.0    2.3            Y  
  ZO-1           49           42         8      72     1.17   6.3    0.7    Y   Y   Y   Y

1: Not high in young CECs (RPM\<100);

2: Not expressed in culture (RPM\<10);

3: Does not differentiate between CEC and stroma (Young/stroma \< 5);

4: Lack of specificity as assessed in BioGPS;

Y: Yes;

?: Not conclusive;

R: retina.

Identification of Genes Important for CEC Function and Physiology {#s2c}
-----------------------------------------------------------------

To identify genes important for CEC physiology, genes that are highly expressed in CEC-DM and CEC cultures were selected and analyzed. The list was filtered for genes with RPM\>10 in young CEC-DM, old CEC-DM and CEC culture, at least two times higher in young CECs than in corneal stroma, and less than 2-fold difference in expression between young and old CEC. The top 50 genes ranked in descending order of expression in young CEC-DM are shown in [Table 4](#pone-0067546-t004){ref-type="table"}. Each gene was analyzed in BioGPS to obtain information on the expression of each gene across different tissues (data not shown). Genes that are not ubiquitously expressed were further analyzed using high-throughput QPCR to compare the expression of these selected genes in various human tissue types.

10.1371/journal.pone.0067546.t004

###### List of top 50 highly expressed genes found in human corneal endothelium that are 2-fold higher in CECs than in stroma, and less than 2-fold difference between young and old corneal endothelium.

![](pone.0067546.t004){#pone-0067546-t004-4}

             RPM Values   Fold Changes                           
  --------- ------------ -------------- -------- -------- ------ -----
  ENO1         35,947        25,205      19,318   14,237   2.5    1.4
  GAPDH        8,083         6,6498      6,598    2,401    3.4    1.2
  CA3          7,804         6,267        166      207     37.7   1.2
  MYOC         6,780         10,193      8,272     915     7.4    0.7
  SLC2A1       5,598         4,593       3,491    1,921    2.9    1.2
  PTGDS        5,547         6,416        184     2,522    2.2    0.9
  IER3         5,311         5,829       1,353    1,779    3.0    0.9
  ATP5B        4,762         4,413       3,095    1,330    3.6    1.1
  TSPAN6       3,860         3,668       1,617     137     28.2   1.1
  MGP          3,598         3,419       3,813     345     10.4   1.1
  ALDOA        3,421         2,425       2,812    1,557    2.2    1.4
  HERPUD1      3,138         2,367        649      862     3.6    1.3
  ATP1A1       2,616         1,627        858      368     7.1    1.6
  ATP5A1       2,586         1,737       1,640     979     2.6    1.5
  GNAS         2,574         2,550       2,112    1,165    2.2    1.0
  PGK1         2,469         2,878       2,239     906     2.7    0.9
  CA12         2,322         1,756       1,721     123     18.8   1.3
  SLC4A11      2,312         2,940        366       90     25.7   0.8
  COX4I1       2,265         2,232       1,011     815     2.8    1.0
  TSC22D1      2,070         2,038       2,978     865     2.4    1.0
  SCD          1,928         1,108        252       54     35.8   1.7
  COL8A2       1,821         1,743        859      107     17.0   1.0
  PFKP         1,577         1,220        433      158     10.0   1.3
  ADM          1,287         1,712        314      491     2.6    0.8
  NDUFB8       1,167          997         664      553     2.1    1.2
  SFRP1        1,134         1,592         38      125     9.0    0.7
  EIF3K        1,070         1,292        648      385     2.8    0.8
  RPL15        1,063         1,033        674      451     2.4    1.0
  GHITM        1,042         1,081        747      224     4.6    1.0
  C5orf62       970           971         472       57     17.1   1.0
  AKR1C1        953           729         678      180     5.3    1.3
  AKR1B1        892           777         988      229     3.9    1.1
  LAMB1         890           825         753       73     12.2   1.1
  ID3           834          1,744       1,337     133     6.3    0.5
  TUBA4A        831           934         191      390     2.1    0.9
  TUFM          767           561         496      302     2.5    1.4
  CD83          750           678          72       81     9.3    1.1
  SULF2         749           470         791       29     25.5   1.6
  NPC2          744           488        1,963     366     2.0    1.5
  TMEM66        632           517         844      321     2.0    1.2
  MIF           628           773         450      314     2.0    0.8
  RGS5          608           930         139       22     27.4   0.7
  C6orf48       603           589         652      290     2.1    1.0
  NDUFB9        589           869         405      234     2.5    0.7
  NDUFB10       583           323         235       98     6.0    1.8
  VDAC3         582           393         299      250     2.3    1.5
  P4HA2         572           231         603      104     5.5    2.0
  ITGB5         571           613        1,333     137     4.2    0.9
  NDUFV1        570           554         104       77     7.4    1.0
  GRHPR         569           667         768      123     4.6    0.9
  ANKH          569           444         687      123     4.6    1.3

Genes are ranked in descending order of RPM values of young CEC-DM. RPM values are rounded off to the nearest integer, and fold change values are rounded off to the nearest decimal place.

QPCR results show that ATP5B is expressed in all the tissue types tested. SLC2A1, ENO1, and COL8A2 are highly expressed in CEC cultures and CEC-DM but are also expressed in many other tissue types, albeit at lower levels. MYOC and SLC4A11 on the other hand are highly expressed in CEC cultures and CEC-DM but not in other tissue types ([Figure 3](#pone-0067546-g003){ref-type="fig"}).

![High-throughput QPCR analysis of genes expressed in both CEC-DM and CEC cultures.\
BM: bone marrow; IVS: interventricular septum; SG: salivary gland; SM: skeletal muscle; SI: small intestine; SC: spinal cord; U/C: uterus/cervix; FB: fetal brain; FL: fetal liver; SF: stromal fibroblast; CC: CEC culture; CEC-DM-y: CEC-DM young; CEC-DM-o: CEC-DM-old.](pone.0067546.g003){#pone-0067546-g003}

Interestingly, the expression of CA3, PTGDS, IER3 and SFRP1 were high in both young and old CEC-DM, but were lost in CEC cultures, indicating that the expression of these genes are not necessary for CEC survival *in vitro*. While they could be useful for identifying CECs *in vivo*, they should not be used as CEC markers in experiments involving CEC cultures. On the other hand, MGP is expressed much higher in CEC cultures than in CEC-DM and other tissue types ([Figure 4](#pone-0067546-g004){ref-type="fig"}).

![High-throughput QPCR analysis of genes differentially expressed in CEC-DM and CEC cultures.\
BM:bone marrow; IVS:interventricular septum; SG: salivary gland; SM: skeletal muscle; SI: small intestine; SC: spinal cord; U/C:uterus/cervix; FB:fetal brain; FL:fetal liver; SF:stromal fibroblast; CC:CEC culture; CEC-DM-y:CEC-DM young; CEC-DM-o:CEC-DM-old.](pone.0067546.g004){#pone-0067546-g004}

Taken together, the results above suggest that SLC4A11 and COL8A2 are suitable markers for CECs based on their high expression in CEC-DM and CEC-cultures compared to other cell types. MYOC is not an ideal choice because it is expressed in the trabecular meshwork where it participates in the obstruction of fluid outflow.

Identifying Genes that are Expressed in CECs but not in Corneal Stroma {#s2d}
----------------------------------------------------------------------

There was a trace amount of SLC4A11 and COL8A2 in corneal stroma keratocytes and/or its activated stromal fibroblasts ([Figure 3](#pone-0067546-g003){ref-type="fig"}). Therefore, we sought to identify other genes that were not expressed or lowly expressed in corneal stroma. We selected genes that have RPM value of less than 1 in corneal stroma but more than 10 in the other 3 samples ([Table 5](#pone-0067546-t005){ref-type="table"}). Each gene was analyzed in BioGPS (data not shown). Genes that are not ubiquitously expressed were chosen for further analyses.

10.1371/journal.pone.0067546.t005

###### Genes not expressed in the corneal stroma.

![](pone.0067546.t005){#pone-0067546-t005-5}

              RPM Values                  
  ---------- ------------ ------- ------- ------
  OLFML1        96.55      69.52   19.64   0.55
  CYYR1         94.39      15.68   10.14   0.00
  HEMK1         91.52      71.61   41.86   0.55
  ACAD8         90.09      26.66   25.90   0.55
  ATRN          75.01      58.54   48.34   0.55
  GNAZ          70.70      70.56   27.84   0.55
  HIPK1         70.70      12.02   17.05   0.00
  FBP1          60.66      65.34   31.07   0.55
  LARS          59.58      26.66   18.99   0.55
  GSTZ1         53.84      47.56   71.64   0.00
  NUP54         51.32      10.98   10.57   0.55
  UBA5          50.96      35.54   13.38   0.55
  UBR7          50.25      35.02   58.70   0.55
  KIAA1549      47.02      36.59   12.08   0.55
  SRGAP2        46.30      17.25   29.13   0.00
  NUAK1         45.22      15.16   26.76   0.55
  ZFPL1         43.79      49.13   90.85   0.55
  UPRT          43.07      28.23   15.11   0.55
  KIF3C         42.71      12.54   11.01   0.55
  UPRT          42.35      28.23   15.11   0.55

Gene list is filtered for RPM\>10 for CEC Young, CEC Old and CEC Culture, and RPM\<1 for corneal stroma. Genes are ranked in descending order of RPM values of CEC Young. All values are rounded off to 2 decimal places.

High throughput QPCR was first performed using Fluidigm Biomark system to compare expression of these genes across different human tissue types. Results show that of all the genes analyzed, CYYR1 was the only gene that was expressed in CEC-DM and CEC cultures, but not expressed in corneal stroma and stroma fibroblast cultures ([Figure 5](#pone-0067546-g005){ref-type="fig"}).

![High-throughput QPCR analysis of genes lowly or not expressed in corneal stroma.\
BM: bone marrow; IVS: interventricular septum; SG: salivary gland; SM: skeletal muscle; SI: small intestine; SC: spinal cord; U/C: uterus/cervix; FB: fetal brain; FL: fetal liver; SF: stromal fibroblast; CC: CEC culture; CEC-DM-y: CEC-DM young; CEC-DM-o: CEC-DM-old.](pone.0067546.g005){#pone-0067546-g005}

Confirming the Stability of Expression of SLC4A11, COL8A2 and CYYR1 across Multiple Biological Samples {#s2e}
------------------------------------------------------------------------------------------------------

QPCR analysis was performed using a 7500 Fast Real Time PCR machine to compare the expression of SLC4A11, COL8A2, and CYYR1 in CECs and corneal stroma from 3 individual donors. Expression of CYYR1 was similar in all three donors (average ± standard deviation: 495±54), while that of SLC4A11 and COL8A2 varied slightly (average ± standard deviation: 318±181 and 126±57 respectively). On average, expression of SLC4A11 was 84-fold higher in CECs than in stroma (*p*\<0.05), while expression of COL8A2 and CYYR1 was 16-fold higher in CECs than in corneal stroma (*p*\<0.05 and *p*\<0.01 respectively). Expression of all three genes was negligible in stromal fibroblast cultures obtained from 2 individual donors ([Figure 6](#pone-0067546-g006){ref-type="fig"}). Taken together, the combination of SLC4A11, COL8A2 and CYYR1 present a useful panel of genes to differentiate between CECs and corneal stroma/stroma fibroblast.

![QPCR validation of gene expression in CEC-DM andcorneal stroma (keratocytes) from 3 individual donors, corneal stromal fibroblast cultures from 2 individual donors and CEC culture.\
CEC: CEC-DM; stroma: corneal stroma (keratocytes); SF: stromal fibroblast. Student's t-tests (two-tailed assuming non-equal variance): One asterisk indicates p\<0.05; two asterisks indicate p\<0.01.](pone.0067546.g006){#pone-0067546-g006}

Gaining Insight into CEC Physiology from Gene Expression {#s2f}
--------------------------------------------------------

The transparency of the cornea is predominantly attributed to the ion and fluid transport capacity of CECs. We were therefore interested to examine the expression of transporters in CECs ([Table S2](#pone.0067546.s002){ref-type="supplementary-material"}). Genes that are classified as transporters under the PANTHER classification system were extracted. The gene list was filtered for RPM\>10 in young CEC-DM, old CEC-DM and CEC culture, at least two times higher in young CECs than in corneal stroma, and less than 2-fold difference in expression between young and old CEC. [Table 6](#pone-0067546-t006){ref-type="table"} shows the list of transporters that fit these criteria, ranked in descending order of expression in young CECs.

10.1371/journal.pone.0067546.t006

###### Expression of transporter-associated genes found in corneal endothelium, cultured corneal endothelial cells and corneal stroma.
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               RPM Values   Fold Changes                       
  ----------- ------------ -------------- ------ ------ ------ -----
  SLC2A1          5598          4593       3491   1921   2.9    1.2
  ATP5B           4762          4413       3095   1330   3.6    1.1
  ATP1A1          2616          1627       858    368    7.1    1.6
  ATP5A1          2586          1737       1640   979    2.6    1.5
  SLC4A11         2313          2940       366     90    25.7   0.8
  SLC25A4         540           536        396    116    4.7    1.0
  ATP6V1E1        402           403        479    188    2.1    1.0
  PCOLCE          397           601        317     42    9.4    0.7
  ATP5G1          236           279        189    113    2.1    0.8
  SLC22A4         231           143         35     5     46.3   1.6
  SORT1           216           237        214     8     27.8   0.9
  SLC15A4         195           358        104     43    4.6    0.5
  SVEP1           182           257        390     11    16.4   0.7
  ATP5J           162           141        129     23    6.9    1.2
  SLC25A11        132            85        152     23    5.8    1.6
  TAP1            128           192        126     6     20.9   0.7
  ATP6V0D1        126           113        245     62    2.0    1.1
  SLC4A4          113           221         41     29    3.9    0.5
  ATP6V1D         109           161        374     43    2.5    0.7
  SLC35E1         107            71         63     11    9.6    1.5
  PAPPA            79            97         89     4     20.2   0.8
  SLC2A3           73            77         18     32    2.3    0.9
  LRPPRC           64            54         37     5     12.9   1.2
  SLC 25A13        59           103         16     12    5.1    0.6
  SLC39A6          59            83         27     14    4.1    0.7
  TM9SF2           55            30         28     19    2.8    1.8
  COX11            55            94         44     24    2.2    0.6
  VPS33B           52            63         33     4     13.4   0.8
  TM9SF1           51            29        191     4     13.1   1.7
  SEC61A2          45            87         15     2     20.1   0.5
  SLC5A3           43            40         22     13    3.3    1.1
  SLC16A2          38            58        304     11    3.6    0.6
  PITPNM1          36            46         33     1     32.7   0.8
  ABCF3            36            36         60     14    2.6    1.0
  TOM1L2           34            24         26     4     7.7    1.4
  SLC26A11         33            28         12     1     30.1   1.2
  SLC35B3          29            36        113     2     17.2   0.8
  SLC16A3          28            38         86     4     6.3    0.7
  SLC4A2           27            51         85     6     4.8    0.5
  CACNB3           27            40         41     1     47.9   0.7
  AP3D1            24            32        114     3     7.2    0.7
  IPO9             22            11         77     6     3.5    1.9
  SLC45A1          18            16         13     1     16.5   1.1

Transporters expressed in CECs that are at least 2 times higher in young CEC-DM than in stroma, and less than 2 fold difference in expression between young and old CEC-DM. Genes are ranked in descending order of RPM values of young CEC-DM. RPM values are rounded off to the nearest integer, and fold change values are rounded off to the nearest decimal place.

The high throughput gene expression analyses performed can also be used to further understand the signaling pathways that govern CEC physiology. To achieve this aim, we looked at the expression of cytokine receptors ([Table S3](#pone.0067546.s003){ref-type="supplementary-material"}) and transcription factors ([Table S4](#pone.0067546.s004){ref-type="supplementary-material"}) in CECs. Genes that are classified as cytokine receptors or transcription factors under the PANTHER classification system were extracted. The gene lists were filtered for RPM\>10 in young CEC-DM, old CEC-DM and CEC culture, at least two times higher in young CECs than in corneal stroma, and less than 2-fold difference in expression between young and old CEC. Only 3 cytokine receptors pass the selection criteria ([Table 7](#pone-0067546-t007){ref-type="table"}). [Table 8](#pone-0067546-t008){ref-type="table"} shows a similar list of transcription factors expressed in CECs.

10.1371/journal.pone.0067546.t007

###### Gene expression of cytokine receptors found in corneal endothelium, cultured corneal endothelial cells and corneal stroma.
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             RPM Values   Fold Changes                  
  --------- ------------ -------------- ---- ---- ----- -----
  TGFBR3        135           130        11   44   3.1   1.0
  IL13RA1        78            95        50   16   4.8   0.8
  IL6ST          43            76        25   9    4.5   0.6

Cytokine receptors expressed in CECs that are at least 2 times higher in young CEC-DM than in stroma, and less than 2 fold difference in expression between young and old CECs. Genes are ranked in descending order of RPM values of young CEC-DM. RPM values are rounded off to the nearest integer, and fold change values are rounded off to the nearest decimal place.

10.1371/journal.pone.0067546.t008

###### Gene expression of transcription factors found in corneal endothelium, cultured corneal endothelial cells and corneal stroma.
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              RPM Values   Fold Changes                     
  ---------- ------------ -------------- ----- ----- ------ -----
  KLF10          566           719        80    195   2.9    0.8
  SNURF          539           272        547   235   2.3    2.0
  PER1           300           192        57    93    3.2    1.6
  ILF2           290           435        379   62    4.7    0.7
  MAFF           289           297        36    119   2.4    1.0
  PITX2          288           567        377   11    27.3   0.5
  TFAP2B         277           244        110    5    45.5   0.9
  SF1            184           244        115   32    5.8    0.5
  SMAD3          180           275        55    38    4.7    0.7
  ERG            127           102        64    24    5.3    1.2
  STAT1          125           212        166   57    2.2    0.6
  SMYD3          122           109        78     2     55    1.1
  TCEB3          118            93        99     6    21.3   1.3
  EPAS1          118           156        90    49    2.4    0.8
  CAND1          118           183        85    49    2.4    0.6
  CAND1          118           183        85    49    2.4    0.6
  REPIN1         113            64        103   12    9.7    1.8
  NFKBIZ         107           110        17    52    2.0    1.0
  KBTBD4         103            64        71    12    8.4    1.6
  L3MBTL2        102            71        23    37    2.7    1.4
  TCEB2          100           128        95    42    2.4    0.8
  POLR3H          95            53        132   35    2.7    1.8
  KLF9            89           141        47    19    4.7    0.6
  GTF2IRD1        81            51        23     1    72.8   1.6
  COPS5           77            88        365   33    2.3    0.9
  RXRB            75            93        50     8    9.1    0.8
  ZNF3            71            84        26    10    7.1    0.8
  ZNF143          67            72        49    31    2.2    0.9
  YAP1            66            67        35     6    10.8   1.0
  ING1            65            96        25     2    29.4   0.7
  ZBTB47          65            36        25     1    58.5   1.8
  ZKSCAN5         63            34        22     2    28.5   1.8
  FOXC1           60           113        24     9    6.7    0.5
  ZNF664          59            50        53    28    2.1    1.2
  ZMYM4           58            61        19     2    34.9   1.0
  SPRYD4          57            36        47    11    5.1    1.6
  TCEAL8          57            54        58    13    4.4    1.0
  ZFHX4           56            81        44     2    33.4   0.7
  E2F4            55            35        35    27    2.1    1.6
  RUVBL2          55            95        153    5    10.9   0.6
  LMX1B           54            38        57     2    24.4   1.4
  TARDBP          52            34        44     8    6.3    1.5
  TBPL1           51            54        18     2    30.6   0.9
  GZF1            48            75        60     3    14.3   0.6
  ZFPL1           44            49        91     1    78.9   0.9
  HCFC2           37            61        16     2     22    0.6
  ZMAT3           36            22        33     8    4.6    1.6
  PCGF3           35            41        13     4    9.0    0.8
  RBX1            34            18        49    14    2.4    1.9
  STAT2           33            57        102    8    4.2    0.6
  CTBP2           32            39        38     3    11.6   0.8
  ZNF862          31            22        11     2    13.7   1.4
  QRICH1          30            30        11     1    54.3   1.0
  CREM            27            52        56     3    9.7    0.5
  EGFL6           23            32        29     1     21    0.7
  RNF14           23            25        19     4    6.0    0.9
  RBL2            23            38        19     4    6.0    0.6
  NFYC            22            33        13     5    4.4    0.7
  CREB3L4         20            19        47     1    36.9   1.1
  CTBP1           20            10        17     3    6.0    1.9
  MAF             20            21        12     6    3.2    0.9
  NFYA            19            14        13     1    34.3   1.4
  ZNF740          16            25        24     2    7.1    0.6

Transcription factors expressed in CECs that are at least 2 times higher in young CEC-DM than in stroma, and less than 2 fold difference in expression between young and old CECs. Genes are ranked in descending order of RPM values of young CEC-DM. RPM values are rounded off to the nearest integer, and fold change values are rounded off to the nearest decimal place.

We next performed pathway analysis of the transcription factors using DAVID Functional Annotation. The signaling pathways represented by the expressed transcription factors include TGFβ and Wnt signaling pathways ([Table 9](#pone-0067546-t009){ref-type="table"}). The expression of components of these signaling pathways were further examined ([Tables S5](#pone.0067546.s005){ref-type="supplementary-material"} and [S6](#pone.0067546.s006){ref-type="supplementary-material"}). Interestingly, we found that CECs do not express all SMADs (intracellular mediators of TGFβ signaling). The most highly expressed SMADs (SMAD2, SMAD3 and SMAD4) in CECs are those involved in the Activin/Nodal branch of TGFβ signaling ([Table 10](#pone-0067546-t010){ref-type="table"}). Such information provides further clues for future work to delineate the signaling pathways controlling CEC physiology and gene expression.

10.1371/journal.pone.0067546.t009

###### Pathway analysis of transcription factors via DAVID Functional Annotation.

![](pone.0067546.t009){#pone-0067546-t009-9}

  Term                           \%                           Genes
  ---------------------------- ------ ------------------------------------------------------
  Pathways in cancer            12.1   CTBP1, CTBP2, EPAS1, RXRB, TCEB2, SMAD3, STAT1, RBX1
  TGF-beta signaling pathway    7.6                E2F4, RBL2,SMAD3,RBX1,PITX2
  Cell cycle                    6.1                   E2F4, RBL2,SMAD3,RBX1
  Wnt signaling pathway         6.1                 CTBP1, CTBP2, SMAD3, RBX1
  Renal cell carcinoma          4.6                     EPAS1, TCEB2, RBX1
  Chronic myeloid leukemia      4.6                    CTBP1, CTBP2, SMAD3

Transcription factors expressed in young CEC-DM, old CEC-DM and CEC culture (RPM\>10) that are more than two-fold higher in young CEC-DM versus stroma, were analyzed in DAVID. Pathways that are over represented are ranked in descending order of percentage of genes representing this category.

10.1371/journal.pone.0067546.t010

###### Expression of SMADs in corneal endothelium, cultured corneal endothelial cells and corneal stroma.
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           RPM Values             
  ------- ------------ ----- ---- -----
  SMAD3       180       275   55   38
  SMAD2       106       45    82   131
  SMAD4        28       11    35    0
  SMAD5        23        0    3     2
  SMAD9        14        0    0     0
  SMAD7        5        46    1     3
  SMAD6        1         0    0     0
  SMAD1        0         5    0     0

Genes are ranked in descending order of RPM values of young CEC-DM. RPM values are rounded off to the nearest integer.

Discussion {#s3}
==========

Expression Markers for CECs {#s3a}
---------------------------

The challenges and important Clinical Quality Assurance (CQA) points that should be taken into consideration for CEC therapy include identity, potency, purity, and safety. To date, no one specific gene has been identified as a marker of CECs. While generic markers such as ZO-1 and Na^+^/K^+^-ATPase indicate the presence of functional fluid transport, they do not definitively identify CECs. Indeed, co-expression of ZO-1 and Na^+^/K^+^-ATPase has been observed in mammalian blastocyst [@pone.0067546-Madan1], [@pone.0067546-Violette1], and in various adult tissues including intestinal epithelium [@pone.0067546-Sugi1] and retinal pigmented epithelium [@pone.0067546-Sonoda1]. The use of our proposed panel of genes (SLC4A11, COL8A2 and CYYR1) together ascertain the identity of the CEC cell type, thereby fulfilling the first CQA point that renders the cell suitable for clinical use.

Both SLC4A11 and COL8A2 are known to play important functions in the cornea. SLC4A11 is a multi-pass membrane protein important for sodium-mediated fluid transport. It prevents morphological abnormalities of the cornea caused by increased sodium chloride concentrations in the stroma. Mutations in SLC4A11 have been known to cause Harboyan Syndrome (congenital corneal endothelial dystrophy with progressive perceptive deafness) [@pone.0067546-Desir1], Corneal Endothelial Dystrophy Type 2 (bilateral corneal dystrophy characterized by corneal opacification and nystagmus) [@pone.0067546-Jiao1], and Fuchs Endothelial Dystrophy (ocular disorder characterized by focal wart-like guttata that arise from DM and develop in the central cornea, epithelial blisters, reduced vision and pain) [@pone.0067546-Riazuddin1].

COL8A2 encodes the alpha 2 chain of type VIII collagen. Type VIII collagen is a major component of the DM [@pone.0067546-Kapoor1]. Mutations in COL8A2 have been shown to cause Fuchs Endothelial Corneal Dystrophy and Posterior Polymorphous Corneal Dystrophy Type 2 [@pone.0067546-Biswas1], [@pone.0067546-Gottsch2], [@pone.0067546-Gottsch3], [@pone.0067546-Kobayashi1], [@pone.0067546-Liskova1], [@pone.0067546-Mok1], [@pone.0067546-Yellore1].

Little is known about CYYR1, also called cysteine and tyrosine-rich protein 1. It is a recently identified gene located on human chromosome 21 whose product has no similarity to any known protein and is of unknown function [@pone.0067546-Vitale1]. Analysis of expressed sequence tags revealed high human CYYR1 expression in cells belonging to the diffuse neuroendocrine system, which may be the origin of neuroendocrine tumors [@pone.0067546-Vitale2].

Differentiating between Corneal Endothelial Cells and Corneal Stroma Cells {#s3b}
--------------------------------------------------------------------------

The inclusion of CYYR1 as part of our panel to identify CECs is crucial, because it helps differentiate CECs from corneal stroma keratocytes and the serum-activated keratocytes known as corneal stroma fibroblasts. This is especially important for researchers studying CEC explants and CEC cultures as slow-growing CECs can be contaminated with, and over-taken by the highly proliferative corneal stroma fibroblasts that may be co-isolated during the isolation of CEC for culture [@pone.0067546-Peh2]. In addition, CECs are the closest to corneal stroma keratocytes in terms of embryonic origin. During development, both cell types are derived from cranial neural crest cells, which migrate and settle in the head mesenchyme. In chick and human, the first wave of migration of mesenchymal cells forms the endothelial layer on the inner surface of the cornea, adjacent to the lens. Shortly thereafter, a second wave of mesenchymal cells invades the primary stroma where the mesenchymal cells differentiate into keratocytes [@pone.0067546-Hay1], [@pone.0067546-Lwigale1]. Therefore, a reliable panel of genes to identify *de novo* CECs generated from pluripotent stem cells must have considerably lower expression in stromal keratocytes/fibroblasts compared to CECs.

Signaling Pathways Controlling CECs Physiology {#s3c}
----------------------------------------------

The high throughput gene expression analysis performed is not only useful for identifying markers for CECs, but also provides insight into the signaling pathways controlling CEC physiology. Examination of the cytokine receptors and transcription factors expressed revealed that TGFβ (in particular the Activin/Nodal branch) and Wnt signaling pathways are active in CECs.

Indeed, exogenous TGFβ in the aqueous humor has been shown to suppress S-phase entry in CEC cultures, suggesting that TGFβ could play a role in the inhibition of proliferation of CECs [@pone.0067546-Joyce2]. In the developing eye, TGFβ from the lens has been shown to control the development of the neural crest--derived eye structures (corneal stroma, corneal endothelium, anterior iris and trabecular meshwork) [@pone.0067546-Ittner1]. The migration of periocular mesenchyme into the region of the prospective corneal stroma and endothelium is attributed to a response to TGFβ signals from the lens. Furthermore, TGFβ2 released from the lens is required for the expression of transcription factors PITX2 and FOXC1 [@pone.0067546-Ittner1], whose expressions in periocular mesenchyme are necessary for the proper formation of the anterior segment of the eye [@pone.0067546-Tumer1].

Wnt signalling has also been implicated in the development of CECs. Canonical Wnt signalling is required for maintenance of PITX2 expression in ocular neural crest cells during cornea development [@pone.0067546-Zacharias1]. Interestingly, the Wnt antagonist DKK2 is an essential downstream target of the PITX2 homeodomain transcription factor in neural crest during eye development, to provide a mechanism to locally suppress canonical Wnt signaling activity during eye development [@pone.0067546-Gage1].

Therefore, manipulation of TGFβ and Wnt signaling pathways in CECs could help improve conditions for *ex vivo* culture of CECs, and direct differentiation of pluripotent stem cells or neural crest cells into CECs.

In conclusion, the high throughput expression analysis of CECs presented in this paper revealed a panel of genes (SLC4A11, COL8A2 and CYYR1) that could be used to identify CECs and proposed pathways (TGFβ and Wnt) that could be explored for expansion of CEC *in vitro* or generation of CECs *de novo*.

Materials and Methods {#s4}
=====================

Research-grade Human Corneoscleral Tissues {#s4a}
------------------------------------------

Research-grade corneoscleral tissues from cadaver human donors considered unsuitable for transplantation were procured from Lions Eye Institute for Transplant and Research Inc. (Tampa, FL, USA). Overall general health of the donor before death was also considered which included previous history or medical treatment that might damage or affect the growth of the corneal endothelium. Research corneas were preserved and transported in Optisol-GS at 4°C, and were used within 13 days from preservation. The ages of donors ranged from 19--76 years ([Table 11](#pone-0067546-t011){ref-type="table"}).

10.1371/journal.pone.0067546.t011

###### Donor information.
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  Serial Number    Age   Sex   Cell Count (OS/OD)        Cause of Death                       
  --------------- ----- ----- -------------------- -------------------------- --- --- --- --- ---
  Single                                                                                      
  01               19     M        2625 (OS)                Overdose           •              
  02               23     F        3891 (OS)             Cholecystitis         •              
  03               23     F        3676 (OS)                 Anoxia            •              
  04               25     M        3344 (OD)                Suicide            •              
  05               32     F        2625 (OS)             Liver Failure         •              
  06               51     F        2865 (OS)                 Sepsis                •          
  07               61     M        2740 (OS)          Acute Cardiac Crisis         •          
  08               57     F        2597 (OD)           Pulmonary Embolism          •          
  09               59     M        2494 (OD)                 Cancer                •          
  10               76     F        2439 (OD)          Acute Cardiac Crisis         •          
  11               19     M        2375 (OD)                 Anoxia                        •  
  12               27     F        2762 (OS)         Multiple Blunt Trauma                 •  
  13               19     M        3846 (OS)                 Sepsis                        •  
  Pairs                                                                                       
  14               31     M    2309 (OS)2398 (OD)           Overdose                   •      
  15               28     M    3096 (OS)2933 (OD)           Overdose                   •      
  16               47     F    2387 (OS)2451 (OD)   Cerebrovascular Accident           •      
  17               19     M    2865 (OS)2717 (OD)          Pneumonia                       •  
  18               74     M    2114 (OS)2045 (OD)    Cardiopulmonary Arrest                    •
  19               34     M    2725 (OS)2801 (OD)            Sepsis                    •      
  20               27     F    2037 (OS)2203 (OD)            Sepsis                    •      

A total of 27 donor corneas consisting of 13 single donor corneas and 7 paired donor corneas were used in this study. Donor age ranged from 19--76.

A: pooled CEC-DM from five young donors;

B: pooled CEC-DM from five old donors;

C: Isolated for cell culture;

D: young CEC-DME control;

E: old CEC-DME control.

OS: oculus sinister.

OD: oculus dexter.

Isolation of Human Corneal Endothelial Cells {#s4b}
--------------------------------------------

Research corneas were incubated in three washes of antibiotic/antimycotic solution in PBS, 15 minutes each. Corneoscleral rims were placed endothelial-side-up on a disposable cornea vacuum punch (Ripon, England), and mildly stabilized by the vacuum suction created. A brief 30 seconds treatment with Trypan Blue solution (0.1%) was used to delineate Schwalbe's line. The CEC-DM layer was carefully stripped off, approximately 1 mm anterior to the Schwalbe's line (away from the trabecular meshwork) from the posterior stroma under the dissecting microscope (Nikon, Japan).

Culture of Human Corneal Endothelial Cells {#s4c}
------------------------------------------

Primary cultures of CECs were established as described in [@pone.0067546-Peh3], and propagated with some modifications. Briefly, the CEC-DM layer was digested enzymatically in collagenase A (2 mg/ml) for at least 2 hours and up to 6 hours. This allowed full detachment of the CECs from the DM, which tended to conglomerate into tightly-packed CEC clusters. The CEC clusters were rinsed once in PBS and further dissociated in TrypLE Express (TE) for 5 minutes. Cell pellets collected after a mild centrifugation (800 g for 5 minutes) were plated in culture-ware coated with FNC coating mixture. Isolated cells were left to adhere overnight in a stabilization medium made up of Human Endothelial-SFM supplemented with 5% FBS and 1x anti-biotic/anti-mycotic. Adhered hCECs were then cultured in F99 medium containing Ham's F12 and M199, mixed in a 1∶1 ratio, supplemented with 5% FBS, 20 µg/ml ascorbic acid, 1x Insulin-Transferrin-Selenium, 1x anti-biotic/anti-mycotic and 10 ng/ml bFGF. When the cultured cells reached 80--90% confluence, they were re-exposed to the stabilization medium for at least one week before passaging [@pone.0067546-Peh4]. Confluent hCECs were passaged using TE, and seeded onto FNC-coated culture ware at a plating density of approximately 10,000 cells per cm^2^ for subsequent passage. All incubation and cultivation of hCECs were carried out in a humidified incubator at 37°C containing 5% CO~2~ unless otherwise stated. Fresh media were replenished every two days.

RNA Extraction {#s4d}
--------------

For direct RNA extraction of donor tissues, isolated CEC-DM and corresponding corneal stroma button, punched out from the donor cornea tissue using an 8.0-mm diameter trephine, were rinsed once in PBS and placed directly into 1 ml Trizol reagent. It should be noted that although most of the corneal epithelium spontaneously sloughed off the cornea surface during the transport and process of the cornea, remnant cells of the basal corneal epithelium might still be present on the corneal stroma button used for RNA extraction. Tissues were homogenized using a hand-held homogenizer before addition of 200 ul of chloroform. After vigorous shaking, samples were spun at 13000 rpm for 15 min at 4°C. The upper phase, containing total RNA, was transferred to a new tube containing an equal volume of 70% ethanol. The resulting solution was transferred into a QIAGEN RNeasy column and procedures were performed as per manufacturer's protocol with a DNAse digestion step incorporated.

RNA Sequencing {#s4e}
--------------

### Reverse transcription and amplification {#s4e1}

RNA-seq libraries were prepared using an AB Demonstrated Protocol similar to the one reported in Tang *et al (2009).* For each sample, 100 pg of total RNA was reverse transcribed by SuperScript III reverse transcriptase (Cat no: 11752-250), using a poly(T) primer with a UP1 anchor sequence (50°C for 30 min followed by an enzyme inactivation step of 70°C for 10 min). The remaining free primers were removed by incubating with Exonuclease I (37°C 30 min, 80°C 25 min). Subsequently, a poly (A) tail was added to the 3′ end of the first strand cDNA by terminal deoxynucleotidyl transferase (37°C for 15 min, and 70°C for 10 min).

The resulting product was split into 4 tubes and used for the synthesis of the second strand cDNA, using a poly(T) primer with another anchor sequence (UP2) and TaKaRa Ex Taq HS, in a volume of 22 µl each (1 cycle of 95°C for 3 min, 50°C for 2 min and 72°C for 6 min). The product of each tube was then separately amplified in a volume of 41 µl, using primers UP1 and UP2 and TaKaRa Ex Taq HS (18 cycles of 95°C for 30 sec, 67°C for 1 min and 72°C for 6 min +6 sec per cycle). The amplified cDNA was combined and purified using a QIAquick PCR purification kit and eluted with 50 µl EB buffer.

The purified cDNA was re-split into 4 tubes and re-amplified with a volume of 90 µl, using 1.2 µl of template for each tube (95°C for 3 min followed by 12 cycles of 95°C for 30 sec, 67°C for 1 min and 72°C 6 min +6 sec per cycle). For this amplification NH2-UP1 and NH2-UP2 primers were used. The amplified cDNA for each sample was then combined, purified and size-selected (500 bp to 3 kb) by gel purification.

### Library preparation {#s4e2}

The ABI standard library preparation protocol (Chapter 2 of AB SOLiD 4 system library preparation guide - PN 4445673) was used for non-barcoded library preparation. The SOLiD fragment library barcoding kit module protocol (AB PN 4443045) was used for barcoded library preparation. The libraries were generated by using the SOLiD fragment library construction kit (PN 4443471) and the SOLiD fragment library barcoding kit (AB PN 4444836).

In brief 1 µg of amplified cDNA was sheared to approximately 165 bp, end repaired and P1, P2 adapters ligated. The product was then nick translated and amplified for 5 cycles before being size selected to be between ∼240 bp to 270 bp. The libraries were further processed using the AB SOLiD 4 system templated bead preparation guide (PN 4448378) and sequenced on 1/8th of a SOLiD slide.

### Alignment and counting {#s4e3}

The resulting RNA-seq reads were processed using the ABI Bioscope pipeline. The reads were aligned to the hg19 human reference genome. Gene expression was measured by counting the number of reads mapping uniquely to both strands of each gene footprint and normalized to the total uniquely mapped reads to the entire genome. The value was adjusted to show reads per million (RPM).

Gene Expression Analysis {#s4f}
------------------------

### Reverse transcription {#s4f1}

Reverse transcription was carried out using Superscript III (Cat no: 11752-250) according to manufacturer's protocol.

### High-throughput Quantitative Polymerase Chain Reaction (QPCR) {#s4f2}

Fluidigm BioMark™System was used for high throughput QPCR and procedures were performed as per manufacturer's protocol. Briefly, 5.6 ng of cDNA and 5x Taqman Gene Expression Assays (Applied Biosystems) were used per reaction and were loaded on a 48×48 Dynamic Array. Data was analyzed using BioMark™ HD System Software Suite. Expression from each gene was normalized to house-keeping genes (GAPDH, ATP6V0E1 and H2AFY) Error bars represent standard deviation from three replicates. The list of primers used can be found in [Table 12](#pone-0067546-t012){ref-type="table"}.

10.1371/journal.pone.0067546.t012

###### Primer list.
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  Gene Name    Array Probe ID   Catalog Number                                      Location of usage
  ----------- ---------------- ---------------- -----------------------------------------------------------------------------------------
  ATP5B        Hs00969569_m1       4331182                           [Figure 3](#pone-0067546-g003){ref-type="fig"}
  CA3          Hs01013316_m1       4331182                           [Figure 4](#pone-0067546-g004){ref-type="fig"}
  COL8A2       Hs00697025_m1       4331182       [Figure 3](#pone-0067546-g003){ref-type="fig"}, [6](#pone-0067546-g006){ref-type="fig"}
  CYYR1        Hs00364793_m1       4331182       [Figure 5](#pone-0067546-g005){ref-type="fig"}, [6](#pone-0067546-g006){ref-type="fig"}
  EEPD1        Hs00286893_m1       4331182                           [Figure 5](#pone-0067546-g005){ref-type="fig"}
  ENO1         Hs00361415_m1       4331182                           [Figure 3](#pone-0067546-g003){ref-type="fig"}
  IER3         Hs00174674_m1       4331182                           [Figure 4](#pone-0067546-g004){ref-type="fig"}
  MGP          Hs00969490_m1       4331182                           [Figure 4](#pone-0067546-g004){ref-type="fig"}
  MYO          Hs00165345_m1       4331182                           [Figure 3](#pone-0067546-g003){ref-type="fig"}
  OLFML1       Hs00416948_m1       4331182                           [Figure 5](#pone-0067546-g005){ref-type="fig"}
  PLK          Hs00288354_m1       4331182                           [Figure 5](#pone-0067546-g005){ref-type="fig"}
  PTGDS        Hs00168748_m1       4331182                           [Figure 4](#pone-0067546-g004){ref-type="fig"}
  SFRP1        Hs00610060_m1       4331182                           [Figure 4](#pone-0067546-g004){ref-type="fig"}
  SLC2A1       Hs00892681_m1       4331182                           [Figure 3](#pone-0067546-g003){ref-type="fig"}
  SLC4A11      Hs00984689_g1       4351372       [Figure 3](#pone-0067546-g003){ref-type="fig"}, [6](#pone-0067546-g006){ref-type="fig"}
  TUB          Hs00163231_m1       4331182                           [Figure 5](#pone-0067546-g005){ref-type="fig"}
  ZNF16        Hs00937483_m1       4331182                           [Figure 5](#pone-0067546-g005){ref-type="fig"}
  ZNF846       Hs01394168_m1       4331182                           [Figure 5](#pone-0067546-g005){ref-type="fig"}
  GAPDH                            4326317E                                         Housekeeping Gene
  ATP6V0E1     Hs00859570_g1       4331182                                          Housekeeping Gene
  H2AFY        Hs00191689_m1       4331182                                          Housekeeping Gene

List of primers used in this study.

### QPCR {#s4f3}

7500 Fast Real-Time PCR System (Life Technologies) was used for QPCR and procedures were performed as per manufacturer's protocol. Briefly, 12.5 ng of cDNA and 2x Taqman Gene Expression Assays (Applied Biosystems) were used per reaction and loaded on a 96-well plate (for Life Technologies PCR system). Expression of each gene was normalized to GAPDH in the same run. Expression levels across samples were normalised to that in CEC culture (100 in CEC culture). Error bars represent standard deviation from three replicates. The list of primers used can be found in [Table 12](#pone-0067546-t012){ref-type="table"}.

Supporting Information {#s5}
======================

###### 

RNAseqpooled_fulldataset. Full data set of RNA sequencing performed on 1) CEC-DM pooled from 5 young donors; 2) CEC-DM pooled from 5 old donors; 3) CEC cultures and 4) Corneal stroma pooled from 5 young donors.

(XLSX)

###### 

Click here for additional data file.

###### 

Transporters. List of transporters (based on PANTHER classification system) and their respective RPM values for young CEC-DM, old CEC-DM, CEC cultures and corneal stroma. This table is a subset of [Table S1](#pone.0067546.s001){ref-type="supplementary-material"}.

(XLSX)

###### 

Click here for additional data file.

###### 

Cytokine Receptors. List of cytokine receptors (based on PANTHER classification system) and their respective RPM values for young CEC-DM, old CEC-DM, CEC cultures and corneal stroma. This table is a subset of [Table S1](#pone.0067546.s001){ref-type="supplementary-material"}.

(XLSX)

###### 

Click here for additional data file.

###### 

Transcription Factors. List of cytokine transcription factors (based on PANTHER classification system) and their respective RPM values for young CEC-DM, old CEC-DM, CEC cultures and corneal stroma. This table is a subset of [Table S1](#pone.0067546.s001){ref-type="supplementary-material"}.

(XLSX)

###### 

Click here for additional data file.

###### 

TGF. List of components of the TGF pathway and their respective RPM values for young CEC-DM, old CEC-DM, CEC cultures and corneal stroma. This table is a subset of [Table S1](#pone.0067546.s001){ref-type="supplementary-material"}.

(XLSX)

###### 

Click here for additional data file.

###### 

Wnt. List of components of the Wnt pathway and their respective RPM values for young CEC-DM, old CEC-DM, CEC cultures and corneal stroma. This table is a subset of [Table S1](#pone.0067546.s001){ref-type="supplementary-material"}.

(XLSX)

###### 

Click here for additional data file.
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